Methods. Data for this study were from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Young adults, African American, and Hispanic respondents were oversampled. Multivariate logistic regression was used to test the association between inhalant use and suicidality, while controlling for other sociodemographic, clinical variables and other potentially confounding variables. Estimates were adjusted to account for the complex survey design, various forms of nonresponse, and to reflect the 2000 census figures for the U.S. population.
Results. A total of 13,733 adults reported that they had experienced a time when they felt sad, blue, or down most of the time or during which they didn't care about/enjoy the things that they usually cared about/enjoyed for at least a 2-week period. Within this sample of lifetime low-mood respondents, inhalant users and persons with formal DSM-IV inhalant use disorders (IUDs) were significantly more likely to be young adults, never married, and to meet criteria for antisocial personality disorder and anxiety disorders than non-users. Suicide attempts were significantly more common among lifetime inhalant users (18.1%) and adults with IUDs (20.2 %) than in non-inhalant users (7.1 %). Suicide attempts were reported by nearly one-third (30.9 %) of adult women who had used inhalants. Respondents with IUDs were significantly more likely to report thinking about committing suicide (OR = 2.2), thinking about wanting to die (OR = 2.0), and thinking about one's own death (OR = 1.7).
Conclusions and Implications. Inhalant use has been called the “forgotten epidemic,” because such use is widespread but rarely addressed in public or professional settings. Suicidal thoughts and attempts are significantly elevated among inhalant users and persons with IUDs. Mental health, chemical dependency, and other social services settings wherein risk for suicide is elevated should routinely screen for inhalant use.